Long-term use of ART in African women of reproductive age

Affiliations

¹ Division of Infectious Diseases, Geffen School of Medicine, Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA 90095, USA; Department of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa. Electronic address: djosephdavey@mednet.ucla.edu.

Comment

Dvora Joseph Davey. Lancet HIV. 2022 Jun.

. 2022 Jun;9(6):e369-e370.

doi: 10.1016/S2352-3018(22)00061-3. Epub 2022 Apr 27.

¹ Division of Infectious Diseases, Geffen School of Medicine, Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA 90095, USA; Department of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa. Electronic address: djosephdavey@mednet.ucla.edu.

No abstract available

Conflict of interest statement

I declare grants and non-financial support from Gilead and personal fees from ViiV.

Effects of long-term antiretroviral therapy in reproductive-age women in sub-Saharan Africa (the PEPFAR PROMOTE study): a multi-country observational cohort study.
Taha TE, Yende-Zuma N, Brummel SS, Stranix-Chibanda L, Wambuzi Ogwang L, Dadabhai S, Chinula L, Nyati MM, Hanley S, Makanani B, Chipato T, Atuhaire P, Aizire J, Fowler MG. Taha TE, et al. Lancet HIV. 2022 Jun;9(6):e394-e403. doi: 10.1016/S2352-3018(22)00037-6. Epub 2022 Apr 27. Lancet HIV. 2022. PMID: 35489365 Free PMC article.